Holding(s) in Company
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi | |||||
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:ii | AstraZeneca PLC | ||||
2 Reason for the notification (please tick the appropriate box or boxes): | |||||
An acquisition or disposal of voting rights | Yes | ||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | No | ||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | No | ||||
An event changing the breakdown of voting rights | No | ||||
Other (please pecify): | |||||
3. Full name of person(s) subject to the notification obligation: iii |
Invesco Limited | ||||
4. Full name of shareholder(s) (if different from 3.):iv |
|||||
5. Date of the transaction and date on which the threshold is crossed or reached: v |
17 April 2014 | ||||
6. Date on which issuer notified: | 17 June 2014 | ||||
7. Threshold(s) that is/are crossed or reached: vi, vii |
5% | ||||
8. Notified details: | ||||||||||||||||
A: Voting rights attached to shares viii, ix | ||||||||||||||||
Class/type of shares |
Situation previous to the triggering transaction |
Resulting situation after the triggering transaction | ||||||||||||||
if possible using the ISIN CODE |
Number of Shares |
Number of Voting |
Number of shares |
Number of voting rights |
% of voting rights x | |||||||||||
Rights | Direct | Direct xi | Indirect xii | Direct | Indirect | |||||||||||
Ordinary Shares GB0009895292 |
72,920,319 | 72,920,319 | 63,033,761 | 4.99% | ||||||||||||
B: Qualifying Financial Instruments | ||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||
Type of financial instrument |
Expiration date xiii |
Exercise/ Conversion Period xiv | Number of voting rights that may be acquired if the instrument is exercised/ converted. |
% of voting rights |
||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | ||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||
Type of financial instrument |
Exercise price | Expiration date xvii | Exercise/ Conversion period xviii |
Number of voting rights instrument refers to | % of voting rights xix, xx | |||||||||||
Nominal | Delta | |||||||||||||||
Total (A+B+C) | ||||||||||||||||
Number of voting rights | Percentage of voting rights | |||||||||||||||
63,033,761 | 4.99% | |||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi |
||
Invesco Advisers Inc. – 182,047 Invesco Asset Management Japan – 75,034 Invesco Asset Management Limited – 16,790,150 Invesco Asset Management S.A (France) – 76,196 Invesco PowerShares Capital Management LLC – 158,278 Invesco GT Management Ltd – 39,146 Invesco Hong Kong Limited – 1,155 Invesco Fund Managers Limited – 45,006,926 Invesco Asset Management Limited GmbH – 667,087 Van Kampen Asset Management – 37,742 |
||
Proxy Voting: | ||
10. Name of the proxy holder: | Invesco Limited | |
11. Number of voting rights proxy holder will cease to hold: |
N/A | |
12. Date on which proxy holder will cease to hold voting rights: |
N/A | |
13. Additional information: |
|
|
14. Contact name: | Sam Edwards | |
15. Contact telephone number: | 01491 416381 | |